Suppr超能文献

靶向纳米系统:用于癌症治疗的靶向树枝状大分子的进展

Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.

作者信息

Yang Hu

机构信息

Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA, USA; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, USA; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.

出版信息

Nanomedicine. 2016 Feb;12(2):309-16. doi: 10.1016/j.nano.2015.11.012. Epub 2015 Dec 17.

Abstract

UNLABELLED

Dendrimers possess discrete highly compact nanostructures constituted of successive branched layers. Soon after the inception of dendrimers, recognition of their tunable structures and biologically favorable properties provoked a great enthusiasm in delving deeply into the utility of dendrimers for biomedical and pharmaceutical applications. One of the most important nanotechnology applications is the development of nanomedicines for targeted cancer therapies. Tremendous success in targeted therapies has been achieved with the use of dendrimer-based nanomedicines. This article provides a concise review on latest advances in the utility of dendrimers in immunotherapies and hormone therapies.

FROM THE CLINICAL EDITOR

Much basic and clinical research has been done since the invention of dendrimers, which are highly branched nano-sized molecules with the ability to act as carriers in nanomedicine. In this concise review article, the authors highlighted the current use of dendrimers in immunotherapies and hormone therapies in the fight against cancers.

摘要

未标注

树枝状大分子具有由连续分支层构成的离散高度紧凑纳米结构。在树枝状大分子诞生后不久,对其可调节结构和生物学有利特性的认识激发了人们深入探究树枝状大分子在生物医学和制药应用中的效用的极大热情。最重要的纳米技术应用之一是开发用于靶向癌症治疗的纳米药物。使用基于树枝状大分子的纳米药物在靶向治疗方面取得了巨大成功。本文简要综述了树枝状大分子在免疫治疗和激素治疗中的最新应用进展。

来自临床编辑

自树枝状大分子发明以来,已经进行了许多基础和临床研究,树枝状大分子是高度分支的纳米级分子,能够在纳米医学中充当载体。在这篇简要综述文章中,作者强调了树枝状大分子目前在对抗癌症的免疫治疗和激素治疗中的应用。

相似文献

1
Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.
Nanomedicine. 2016 Feb;12(2):309-16. doi: 10.1016/j.nano.2015.11.012. Epub 2015 Dec 17.
2
Recent progress in dendrimer-based nanomedicine development.
Arch Pharm Res. 2018 Jun;41(6):571-582. doi: 10.1007/s12272-018-1008-4. Epub 2018 Feb 15.
3
From metallodrugs to metallodendrimers for nanotherapy in oncology: a concise overview.
Curr Med Chem. 2012;19(29):4995-5010. doi: 10.2174/0929867311209024995.
5
Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
Bioconjug Chem. 2020 Sep 16;31(9):2060-2071. doi: 10.1021/acs.bioconjchem.0c00395. Epub 2020 Aug 26.
6
Dendrimers for pharmaceutical and biomedical applications.
J Biomater Sci Polym Ed. 2006;17(1-2):3-19. doi: 10.1163/156856206774879171.
8
Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.
Chem Commun (Camb). 2011 Sep 14;47(34):9572-87. doi: 10.1039/c1cc11981h. Epub 2011 Jun 9.
9
Recent advances in targeted drug delivery approaches using dendritic polymers.
Biomater Sci. 2015 Jul;3(7):1025-34. doi: 10.1039/c4bm00351a. Epub 2014 Dec 11.
10
Designing Dendrimer and Miktoarm Polymer Based Multi-Tasking Nanocarriers for Efficient Medical Therapy.
Molecules. 2015 Sep 17;20(9):16987-7015. doi: 10.3390/molecules200916987.

引用本文的文献

2
Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment.
Int J Mol Sci. 2024 Oct 19;25(20):11235. doi: 10.3390/ijms252011235.
3
Anti-biofilm, drug delivery and cytotoxicity properties of dendrimers.
ADMET DMPK. 2024 Feb 14;12(2):239-267. doi: 10.5599/admet.1917. eCollection 2024.
4
Guanidinium-based Integrated Peptide Dendrimers: Pioneer Nanocarrier in Cancer Therapy.
Protein Pept Lett. 2024;31(4):261-274. doi: 10.2174/0109298665292042240325052536.
5
Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer.
Molecules. 2024 Feb 29;29(5):1076. doi: 10.3390/molecules29051076.
6
Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment-An Overview.
Pharmaceutics. 2023 May 4;15(5):1406. doi: 10.3390/pharmaceutics15051406.
7
Dendrimer Technology in Glioma: Functional Design and Potential Applications.
Cancers (Basel). 2023 Feb 8;15(4):1075. doi: 10.3390/cancers15041075.
9
The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells.
Nanoscale Adv. 2022 Aug 24;4(18):4009-4015. doi: 10.1039/d2na00308b. eCollection 2022 Sep 13.
10
Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.
Nanoscale Adv. 2020 Aug 24;2(11):5046-5089. doi: 10.1039/d0na00478b. eCollection 2020 Nov 11.

本文引用的文献

1
Click synthesis of a polyamidoamine dendrimer-based camptothecin prodrug.
RSC Adv. 2015;5(72):58600-58608. doi: 10.1039/C5RA07987J. Epub 2015 Jun 29.
2
Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery.
Int J Nanomedicine. 2015 Aug 28;10:5489-503. doi: 10.2147/IJN.S87145. eCollection 2015.
4
PAMAM Dendrimer/pDNA Functionalized-Magnetic Iron Oxide Nanoparticles for Gene Delivery.
J Biomed Nanotechnol. 2015 Aug;11(8):1370-84. doi: 10.1166/jbn.2015.2101.
5
Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo.
PLoS One. 2015 Jul 13;10(7):e0132215. doi: 10.1371/journal.pone.0132215. eCollection 2015.
6
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking.
Front Chem. 2014 Nov 26;2:105. doi: 10.3389/fchem.2014.00105. eCollection 2014.
7
Protective effects and mechanisms of G5 PAMAM dendrimers against acute pancreatitis induced by caerulein in mice.
Biomacromolecules. 2015 Jan 12;16(1):174-82. doi: 10.1021/bm501390d. Epub 2014 Dec 16.
9
Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications.
J Intern Med. 2014 Dec;276(6):579-617. doi: 10.1111/joim.12280. Epub 2014 Jul 31.
10
Avidity mechanism of dendrimer-folic acid conjugates.
Mol Pharm. 2014 May 5;11(5):1696-706. doi: 10.1021/mp5000967. Epub 2014 Apr 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验